Ian Bezek

Ian Bezek

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

The 7 Most Undervalued Blue-Chip Stocks to Buy Now: June 2023

Want to buy good companies at a good price? Check out these seven undervalued blue-chip stocks today.

Betting Against the Market: 3 Stocks at Risk as Short Bets Reach a One-Year High

With speculation is running rampant, be sure to avoid these three stocks at risk of short selling to stay safe in the months ahead.

3 Space Stocks to Buy With Explosive Upside Potential

Humanity appears to be on the threshold of key breakthroughs in the stars. That bodes well for these three top space stocks to buy.

Time’s Ticking: Dump These 3 Overvalued Penny Stocks

Penny stock investors need to stay far away from these three overvalued penny stocks from disastrous companies.

7 Tech Stocks to Buy With Explosive Upside Potential

Discover these seven tech stocks with humungous upside before they lift off.

3 Stocks to Sell Now Before Overvaluation Kicks In

The market is surging. But don't get stuck holding the bag with these three overvalued stocks to sell when the correction comes.

Don’t Get Trapped in These 3 Overvalued Blue-Chips

These blue-chip stocks aren't nearly as safe as they might sound given their inflated P/E ratios.

Discover Hidden Growth Potential of These 3 Blue-Chip Stocks

The best blue-chip stocks to buy are high-quality firms with attractive growth prospects that can lead to capital appreciation.

3 Long-term Healthcare Stocks to Add to Your Portfolio

These long-term healthcare stocks should benefit from the global surge in spending for life-improving pharmaceutical drugs, therapies, and medical devices.

Stability Meets Growth: 3 Undervalued Blue-Chip Stock Picks

Whether or not the recent bull market can sustain itself, these conservative blue-chip stocks are poised to deliver favorable returns.